Carvedilol
For Laboratory Research Only. Not for Clinical or Personal Use.
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Carvedilol
Description :
Carvedilol (BM 14190) is a non-selective β/α-1 blocker[1]. Carvedilol inhibits lipid peroxidation in a dose-dependent manner with an IC50 of 5 μM. Carvedilol is a multiple action antihypertensive agent with potential use in angina and congestive heart failure[2]. Carvedilol is an autophagy inducer that inhibits the NLRP3 inflammasome[3].Product Name Alternative :
BM 14190UNSPSC :
12352005Hazard Statement :
H410Target :
Adrenergic Receptor; Autophagy; BacterialType :
Reference compoundRelated Pathways :
Anti-infection; Autophagy; GPCR/G Protein; Neuronal SignalingApplications :
Cancer-programmed cell deathField of Research :
Cancer; Inflammation/Immunology; Cardiovascular DiseaseAssay Protocol :
https://www.medchemexpress.com/carvedilol.htmlConcentration :
10mMPurity :
99.98Solubility :
DMSO : 100 mg/mL (ultrasonic)Smiles :
OC(CNCCOC1=CC=CC=C1OC)COC2=CC=CC(N3)=C2C4=C3C=CC=C4Molecular Formula :
C24H26N2O4Molecular Weight :
406.47Precautions :
H410References & Citations :
[1]Eggertsen R, et al. Acute haemodynamic effects of carvedilol (BM 14190), a new combined beta-adrenoceptor blocker and precapillary vasodilating agent, in hypertensive patients. Eur J Clin Pharmacol. 1984;27 (1) :19-22.|[2]Feuerstein GZ, et al. Myocardial protection by the novel vasodilating beta-blocker, carvedilol: potential relevance of anti-oxidant activity. J Hypertens Suppl. 1993 Jun;11 (4) :S41-8.|[3]Wong WT, et al. Repositioning of the β-Blocker Carvedilol as a Novel Autophagy Inducer That Inhibits the NLRP3 Inflammasome. Front Immunol. 2018 Aug 22;9:1920.Shipping Conditions :
Room TemperatureStorage Conditions :
-20°C, 3 years; 4°C, 2 years (Powder)Scientific Category :
Reference compound1Clinical Information :
LaunchedCAS Number :
[72956-09-3]

